Estatísticas Básicas
| CIK | 1500123 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Item 9 Labs Corp.
SEC Filings (Chronological Order)
Esta página fornece uma lista completa e cronológica de Arquivamentos da SEC, excluindo os arquivamentos de propriedade que fornecemos em outro lugar.
| February 21, 2024 |
INLB / Item 9 Labs Corp. / Clearthink Capital Partners, LLC - SCHEDULE 13G Passive Investment SC 13G 1 ea0200320-13gclearitem9.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 ITEM 9 LABS CORP (Name of Issuer) Common Stock (Title of Class of Securities) 46564C203 (CUSIP Number) September 30, 2022 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| August 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| August 14, 2023 |
Item 9 Labs Corp. (Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo |
|
| July 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: July 20, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorpora |
|
| July 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: July 7, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporat |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 27, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorpora |
|
| June 6, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 6, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporat |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 22, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporat |
|
| May 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| May 15, 2023 |
Item 9 Labs Corp. (Name of Registrant as Specified in Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on F |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 12, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporat |
|
| May 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 4, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorporati |
|
| April 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: April 5, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorpora |
|
| March 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 10, 2023 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorpor |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| January 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED) For the fiscal year ended September 30, 2022 ☐ TRANSACTION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transaction period from to ITEM 9 LABS CORP. (Exact name of regis |
|
| December 29, 2022 |
Item 9 Labs Corp. (Name of Registrant as Specified in Charter) NT 10-K 1 inlb1229formnt10k.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2022 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transit |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 30, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incor |
|
| November 30, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Appoints Mike Weinberger to CEO Ahead of Approaching Transformational Acquisition Previously the Company?s Chief Franchise Officer, the 20-Year Franchise Veteran Takes Helm to Lead through International Cannabis Franchise Growth PHOENIX (November 30, 2022) ? With a transformative acquisition approaching, Item 9 Labs Corp. (OTCQX: INLB) (the ?Com |
|
| October 11, 2022 |
Registration Rights Agreement by and between the Company and ClearThink Capital Partners, LLC Exhibit 10.1 REGISTRATION RIGHTS AGREEMENT THIS REGISTRATION RIGHTS AGREEMENT (this ?Agreement?), dated as of August 24, 2022, by and between ITEM 9 LABS CORP., a Delaware corporation (the ?Company?), and CLEARTHINK CAPITAL PARTNERS, LLC, a Delaware limited liability company (together with it permitted assigns, the ?Buyer?). Capitalized terms used herein and not otherwise defined herein shall have |
|
| October 11, 2022 |
Securities Purchase Agreement by and between the Company and ClearThink Capital Partners, LLC Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this ?Agreement?), dated as of September 6, 2022, is entered into by and between Item 9 Labs Corp., a Delaware corporation, (the ?Company?), and ClearThink Capital Partners, LLC, a Delaware limited liability company (the ?Buyer?). A. The Company and the Buyer are executing and delivering this Agreement in reliance upon |
|
| October 11, 2022 |
Purchase Agreement by and between the Company and ClearThink Capital Partners, LLC Exhibit 10.3 PURCHASE AGREEMENT THIS PURCHASE AGREEMENT (the ?Agreement?), dated as of September 6, 2022, is entered into by and between ITEM 9 LABS CORP., a Delaware corporation (the ?Company?), and CLEARTHINK CAPITAL PARTNERS, LLC, a Delaware limited liability company (the ?Investor?). WHEREAS: Subject to the terms and conditions set forth in this Agreement, the Company wishes to sell to the Inv |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 11, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer Identification No.) of incorp |
|
| August 16, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Items 9 Labs Corp. Reports 12% Growth to $17.8 Million Revenue for the Nine Months Ended June 30, 2022 ? Company?s National Unity Rd. Dispensary Franchise Continues to Pave Way in the Industry, Opens First Non-Tribal, State-Licensed Medical Cannabis Establishment in the State of South Dakota and Second Colorado Store ? Signs Definitive Agreement to Acquire Sessio |
|
| August 16, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 16, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificati |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| June 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 3, 2022 (June 1, 2022) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employ |
|
| May 24, 2022 |
Share Purchase Agreement dated May 18, 2022 Exhibit 2.1 SHARE PURCHASE AGREEMENT among STEVEN FRY, and NAJLA GUTHRIE, and DARRYL ALLEN, and LOUIS LASKOVSKI, and 11949896 CANADA INC., and 2628146 ONTARIO LTD., and ITEM 9 LABS CORP., and OCG MANAGEMENT ONTARIO INC. Dated as of May 18, 2022. TABLE OF CONTENTS Article 1 DEFINITIONS 2 1.1 Definitions 2 1.2 Certain Rules of Interpretation 17 Article 2 PURCHASE AND SALE 18 2.1 Purchase and Sale 18 |
|
| May 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 24, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification |
|
| May 24, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Signs Definitive Agreement to Acquire Sessions Cannabis, One of Canada’s Largest Cannabis Retail Franchisors - Transformative Acquisition Creates the Largest, Global and Publicly Traded Cannabis Franchise Company - Sessions Cannabis Generates Approximately CA$70 Million in Annual Systemwide Sales With 43 Stores Currently Open PHOENIX (May 25, 20 |
|
| May 16, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million ? National Unity Rd. Dispensary Franchise Footprint Expands into Three New States ? Cultivation, Production and Processing Expansion in Nevada Nears Completion with Phase One of Arizona Development also on Track ? Management to Host Conference Call and W |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| May 16, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 16, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification |
|
| May 4, 2022 |
SUPPLEMENT NO 1. DATED MAY 4, 2022 TO THE OFFERING CIRCULAR DATED FEBRUARY 25, 2022 ITEM 9 LABS CORP Filed pursuant to Rule 253(g)(2) File No. 024-11795 SUPPLEMENT NO 1. DATED MAY 4, 2022 TO THE OFFERING CIRCULAR DATED FEBRUARY 25, 2022 OF ITEM 9 LABS CORP This document supplements, and should be read in conjunction with, the Offering Circular (the “Offering Circular”) dated February 25, 2022 of Item 9 Labs Corp (the “Company”). Unless otherwise defined in this supplement, capitalized terms used |
|
| March 18, 2022 |
Item 9 Labs Corp. to Acquire The Herbal Cure in Denver, Colorado Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. to Acquire The Herbal Cure in Denver, Colorado - Future Flagship Corporate Location Generated $5.4 Million in Revenue in 2021 - Second Colorado Acquisition Fuels Market Expansion for the Company?s Dispensary Franchise, Unity Rd. - Acquisition Includes Cultivation License, Complementing the Company?s National Retail and Product Expansion Efforts |
|
| March 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 17, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificatio |
|
| March 18, 2022 |
Asset Purchase Agreement dated March 11, 2022 Exhibit 2.1 ASSET PURCHASE AGREEMENT between THE HERBAL CURE LLC (?Seller?) and UNITY RD LOGAN CO LLC (?Buyer?) dated as of March 10th, 2022 (the ?Effective Date?) 1 TABLE OF CONTENTS ARTICLE I DEFINITIONS ARTICLE II PURCHASE AND SALE ARTICLE III CLOSING ARTICLE IV REPRESENTATIONS AND WARRANTIES OF SELLER ARTICLE V REPRESENTATIONS AND WARRANTIES OF BUYER ARTICLE VI COVENANTS ARTICLE VII CONDITIONS |
|
| March 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 4, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification |
|
| March 4, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Closes Acquisition of Adams County, Colorado Dispensary Franchisor of Cannabis Dispensary, Unity Rd. Seeks to Keep Dispensary Ownership Local by Providing Turnkey Investment Opportunities for New and Existing Franchise Partners DENVER (March 4, 2022) ? Item 9 Labs Corp. (OTCQX: INLB) (the ?Company?) ? a vertically integrated cannabis dispensary |
|
| March 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 2, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification |
|
| March 2, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Strengthens Board of Directors with Appointment of Massage Heights Founder Leading Cannabis Dispensary Franchisor Names Shane Evans to Board; Adds 20-Plus Years of Franchise and Wellness Industry Experience PHOENIX (March 2, 2022) - Item 9 Labs Corp. (OTCQX: INLB) (the ?Company?) ? the first true vertically integrated cannabis dispensary franchi |
|
| February 23, 2022 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Offering Statement on Form 1-A of our report dated January 13, 2022, relating to the financial statements of Item 9 Labs Corp. as of September 30, 2021 and to all references to our firm included in this Registration Statement. Certified Public Accountants Lakewood, CO February 21, 2 |
|
| February 23, 2022 |
CORRESP 1 filename1.htm February 23, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attn: Jane Park , SEC Examiner Re: Item 9 Labs Corp. (the “Company”) Offering Statement on Form 1-A (File No. 024-11795) Qualification Request Ladies and Gentlemen: We respectfully request that the Company’s above-referenced Offering |
|
| February 23, 2022 |
Consent of Independent Registered Public Accounting Firm Exhibit 11.3 Consent of Independent Registered Public Accounting Firm Item 9 Labs Corp. Phoenix, Arizona We hereby consent to the use in the Form 1-A filing of our report dated January 12, 2021, relating to the consolidated financial statements of Item 9 Labs Corp. appearing in the Company?s Annual Report on Form 10-K for the fiscal year ended September 30, 2020. We also consent to the reference t |
|
| February 23, 2022 |
Exhibit 3.1 [FORM OF WARRANT] WARRANT HOLDER: NUMBER OF WARRANT SHARES: THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN QUALIFIED PURSUANT TO REGULATION A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?) AND ARE EXEMPT FROM REGISTRATION UNDER STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FO |
|
| February 23, 2022 |
PART II—INFORMATION REQUIRED IN OFFERING CIRCULAR PRELIMINARY OFFERING CIRCULAR PART II—INFORMATION REQUIRED IN OFFERING CIRCULAR PRELIMINARY OFFERING CIRCULAR An Offering Statement pursuant to Regulation A relating to these shares has been filed with the U. |
|
| February 15, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Announces First Quarter FY 2022 Financial Results with Revenue Growth of 104% to $6.2 Million - Cultivation, Production and Processing Expansion in Arizona and Nevada is Advancing as Expected - Unity Rd. Targets a Significant Number of Cannabis Dispensary Openings by the End of 2022 - Management to Host Conference Call and Webcast to Discuss Key |
|
| February 15, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: February 15, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identifica |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| February 8, 2022 |
United States securities and exchange commission logo February 8, 2022 Robert Mikkelsen Chief Financial Officer Item 9 Labs Corp. |
|
| February 2, 2022 |
PART II—INFORMATION REQUIRED IN OFFERING CIRCULAR PRELIMINARY OFFERING CIRCULAR PART II AND III 2 inlb0125form1a.htm FORM 1-A PART II & III PART II—INFORMATION REQUIRED IN OFFERING CIRCULAR PRELIMINARY OFFERING CIRCULAR An Offering Statement pursuant to Regulation A relating to these shares has been filed with the U.S. Securities and Exchange Commission (the “Commission”). Information contained in this preliminary Offering Circular is subject to completion or amendment. These |
|
| February 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: February 1, 2022 (January 26, 2022) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IR |
|
| February 2, 2022 |
[FORM OF SUBSCRIPTION AGREEMENT] ITEM 9 LABS CORP. SUBSCRIPTION AGREEMENT Exhibit 4.1 [FORM OF SUBSCRIPTION AGREEMENT] ITEM 9 LABS CORP. SUBSCRIPTION AGREEMENT THIS INVESTMENT INVOLVES A HIGH DEGREE OF RISK. THIS INVESTMENT IS SUITABLE ONLY FOR PERSONS WHO CAN BEAR THE ECONOMIC RISK FOR AN INDEFINITE PERIOD OF TIME AND WHO CAN AFFORD TO LOSE THEIR ENTIRE INVESTMENT. FURTHERMORE, INVESTORS MUST UNDERSTAND THAT SUCH INVESTMENT IS ILLIQUID AND IS EXPECTED TO CONTINUE TO BE |
|
| February 2, 2022 |
Consent of Independent Registered Public Accounting Firm Exhibit 11.3 Consent of Independent Registered Public Accounting Firm Item 9 Labs Corp. Phoenix, Arizona We hereby consent to the use in the Form 1-A filing of our report dated January 12, 2021, relating to the consolidated financial statements of Item 9 Labs Corp. appearing in the Company?s Annual Report on Form 10-K for the fiscal year ended September 30, 2020. We also consent to the reference t |
|
| February 2, 2022 |
Exhibit 12.1 February 1, 2022 Item 9 Labs Corp. 2727 N 3rd Street, Suite 201 Phoenix, AZ 85004 Attn: Board of Directors Re: Regulation A—Tier 2 Offering Ladies and Gentlemen: We have acted, at your request, as special counsel to Item 9 Labs Corp., a Delaware corporation (the “Company”), for the purpose of rendering an opinion as to the legality of units (the “Units”), each Unit comprised of (i) on |
|
| February 2, 2022 |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM Exhibit 11.2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation in this Offering Statement on Form 1-A of our report dated January 13, 2022, relating to the financial statements of Item 9 Labs Corp. as of September 30, 2021 and to all references to our firm included in this Registration Statement. Certified Public Accountants Lakewood, CO February 2, 20 |
|
| February 2, 2022 |
Exhibit 3.1 [FORM OF WARRANT] WARRANT HOLDER: NUMBER OF WARRANT SHARES: THE SECURITIES REPRESENTED HEREBY AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN QUALIFIED PURSUANT TO REGULATION A OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?) AND ARE EXEMPT FROM REGISTRATION UNDER STATE SECURITIES LAWS. THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FO |
|
| January 18, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 18, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificat |
|
| January 18, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Reports Record FY 2021 Annual Financial Results with Revenue Growth of 170% to $21.9 Million Revenue - Cultivation, Production and Processing Expansion Ongoing in Arizona and Nevada - Unity Rd. Brand Accelerates Ramp by Signing Ten Agreements for National Cannabis Dispensary Franchise Expansion - Management to Host Conference Call and Webcast to |
|
| January 13, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED) For the fiscal year ended September 30, 2021 ? TRANSACTION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transaction period from to ITEM 9 LABS CORP. (Exact name of regis |
|
| January 11, 2022 |
Item 9 Labs Corp. to Host its Fiscal Year 2021 Earnings Call on January 18 at 2 p.m. ET Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. to Host its Fiscal Year 2021 Earnings Call on January 18 at 2 p.m. ET PHOENIX (January 11, 2022) - Item 9 Labs Corp. (OTCQX: INLB) (the ?Company?)?a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-winning products?announced today that it will host a conference call on Tuesday, January 18, 2022 to di |
|
| January 11, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 11, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificat |
|
| January 4, 2022 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Enhances Board of Directors with Two Independent Appointments Names Eric C. Kutscher and Lawrence X. Taylor to Board of Directors; Adds a Combined 55-Plus Years of Experience Across Patient-Centered Healthcare, Leadership, M&A and Strategic Planning PHOENIX, Ariz. (Jan. 4, 2022) ? Item 9 Labs Corp. (OTCQX: INLB) (the ?Company?)?a vertically inte |
|
| January 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 4, 2022 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificati |
|
| December 30, 2021 |
Item 9 Labs Corp. (Name of Registrant as Specified in Charter) NT 10-K 1 inlb1229formnt10k.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transit |
|
| November 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 3, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificat |
|
| November 4, 2021 |
Exhibit 16.1 November 3, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Ladies and Gentlemen: We have read Item 4.01 of Form 8-K dated November 3, 2021, of Item 9 Labs Corp. and are in agreement with the statements contained therein, insofar as it relates to our firm. We have no basis to agree or disagree with other statements of the registrant contained therein. S |
|
| October 7, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 7, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificati |
|
| October 7, 2021 |
Asset Purchase Agreement dated October 6, 2021 Exhibit 2.1 For execution ASSET PURCHASE AGREEMENT Dated as of October 6, 2021 between Item 9 Labs Colorado LLC As Buyer LLC, Item 9 Labs Corp. As PubCo, And Nebrina Adams County LLC, As Seller TABLE OF CONTENTS 1. Terms of Transactions. 3 2. Closing. 8 3. Representations and Warranties of Seller. 10 4. Representations and Warranties of Buyer LLC. 20 5. Indemnification. 21 6. Conditions to Closing |
|
| October 7, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. to Acquire Colorado Dispensary, Kickstarts National Acquisition Growth Plan Franchisor of Cannabis Dispensary Franchise, Unity Rd., to Aggressively Expand by Converting Cannabis Retail Stores into Unity Rd. Shops; Company Seeks to Keep Dispensary Ownership Local by Providing Turnkey Investment Opportunities for New and Existing Unity Rd. Franchi |
|
| September 30, 2021 |
Exhibit 99.1 OCG, Inc. and Subsidiaries Consolidated Financial Statements For the years ended December 31, 2020 and December 31, 2019 TABLE OF CONTENTS Page INDEPENDENT AUDITOR?S REPORT 1 CONSOLIDATED BALANCE SHEETS 2 CONSOLIDATED STATEMENTS OF OPERATIONS 3 CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS? DEFICIT 4 CONSOLIDATED STATEMENTS OF CASH FLOWS 5 NOTES TO THE FINANCIAL STATEMENTS 6 Repo |
|
| September 30, 2021 |
UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION Exhibit 99.2 UNAUDITED PRO FORMA COMBINED FINANCIAL INFORMATION On March 19, 2021, I9 Acquisition Sub Inc., a Colorado corporation (?Merger Sub?) and a wholly-owned subsidiary of Item 9 Labs Corp (?Item 9? or the ?Company?), merged with and into OCG, Inc., a Colorado corporation (?OCG?), whereby OCG continued as the surviving corporation and became a wholly-owned subsidiary of Item 9 pursuant to t |
|
| September 30, 2021 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 23, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File N |
|
| August 31, 2021 |
Filed with the SEC on August 31, 2021 as part of our Current Report on Form 8-K. EX-10.2 3 inlb0830form8kexh102.htm EXHIBIT 10.2 Exhibit 10.2 THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS ARE SUBJECT TO STRICT REQUIREMENTS FOR ONGOING REGULATORY COMPLIANCE BY THE PARTIES HERETO, INCLUDING, WITHOUT LIMITATION, REQUIREMENTS THAT THE PARTIES TAKE NO ACTION IN VIOLATION OF EITHER ANY STATE CANNABIS LAWS OR THE GUIDANCE OR INSTRUCTION OF THE REGULATOR. SECTION 8.21 OF THIS AGREEMENT |
|
| August 31, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 31, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificati |
|
| August 31, 2021 |
Filed with the SEC on August 31, 2021 as part of our Current Report on Form 8-K. Exhibit 10.1 THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS ARE SUBJECT TO STRICT REQUIREMENTS FOR ONGOING REGULATORY COMPLIANCE BY THE PARTIES HERETO, INCLUDING, WITHOUT LIMITATION, REQUIREMENTS THAT THE PARTIES TAKE NO ACTION IN VIOLATION OF EITHER ANY STATE CANNABIS LAWS OR THE GUIDANCE OR INSTRUCTION OF THE REGULATOR. SECTION 8.21 OF THIS AGREEMENT CONTAINS SPECIFIC REQUIREMENTS AND COMMITMENTS B |
|
| August 31, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Secures $19 Million Construction-Financing Loan with Pelorus Equity Group for Expansion of Cultivation & Lab Sites in Arizona & Nevada Financing to Fund Master Site Expansion in Arizona, including Acquisition of the 45 acres of Adjacent Land Next to the Company's Existing 19,200 sq. ft. Facility Capacity of Arizona Operations to be Enhanced by 3 |
|
| August 17, 2021 |
Item 9 Labs Corp. Reports Record Third Quarter FY 2021 Financial Results Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Reports Record Third Quarter FY 2021 Financial Results - Company Posts Record Quarterly Revenue of $6.7 Million, up 203% YOY - Quarterly Revenue Grew 10% Sequentially, Marking Seven Consecutive Quarters of Positive Growth - Opens First Cannabis Dispensary Franchise Shop under the Unity Rd. Brand and Signs Five Agreements for Franchise Expansion |
|
| August 17, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 17, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificati |
|
| August 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| June 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: June 17, 2021 (June 11, 2021) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Empl |
|
| May 18, 2021 |
EX-99.1 2 inlb0517form8kexh991.htm EXHIBIT 99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE: Item 9 Labs Achieves Profitability for Second Quarter Fiscal Year 2021, Marking 6 Consecutive Quarters of Revenue Growth Company reaches quarterly sales of $6.1 million, up 228% year over year and up 101% sequentially First quarter of positive net income in Company’s history fueled by robust market demand, increase |
|
| May 18, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0517form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 18, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorpora |
|
| May 17, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| May 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 11, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identification |
|
| May 12, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Adds Expertise to Strengthen its Board of Directors Appoints Law Enforcement Veteran Joe DiSalvo and Chief Franchise Officer Mike Weinberger to Board of Directors PHOENIX ? May 12, 2021 ? Item 9 Labs Corp. (OTCQX: INLB) (?Item 9 Labs? or the ?Company?), a vertically integrated cannabis dispensary franchisor and operator that produces premium, award-wi |
|
| May 12, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0512form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 12, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorpora |
|
| March 23, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Closes Acquisition of Leading U.S. Cannabis Dispensary Franchisor Acquisition of ONE Cannabis Group, Parent Company of Dispensary Franchise Unity Rd., Paves a New Path of Industry Innovation as the Leading National Vertically Integrated Cannabis Franchise Company PHOENIX (March 23, 2021) – Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs” or the “C |
|
| March 23, 2021 |
EX-2.1 2 inlb0323form8kexh21.htm EXHIBIT 2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among ITEM 9 LABS CORP. and I9 ACQUISITION SUB, INC. and OCG, INC. and PRINCIPALS and STOCKHOLDER REPRESENTATIVE December 13, 2020 TABLE OF CONTENTS Article I Definitions 2 Article II The Merger 16 Section 2.01 The Merger. 16 Section 2.02 Closing. 16 Section 2.03 Closing Deliverables. 16 Section 2.04 Effective Ti |
|
| March 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 23, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificatio |
|
| February 16, 2021 |
Exhibit 99.1 FOR IMMEDIATE RELEASE: Item 9 Labs Reports Record Revenue of $3.0 Million for First Quarter Fiscal Year 2021, Up 98% Year over Year Revenue growth fueled by strong market demand and increases in cannabis production Gross margin improvement reflects increased operating efficiencies Company is poised for accelerated revenue growth in 2021, driven by adult-use legalization in Arizona, ap |
|
| February 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| February 16, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0215form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: February 16, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of inco |
|
| February 3, 2021 |
- SCHEDULE 14C DEFINITIVE INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Definitive Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Sheet ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☑ Definitive Information Statement ITEM 9 LABS CORP. (Exact name of registra |
|
| January 25, 2021 |
- SCHEDULE 14C (AMENDMENT NO. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Amendment No. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☑ Preliminary Information Sheet ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ITEM 9 LABS CORP. (Exact name of reg |
|
| January 13, 2021 |
Item 9 Labs Reports Record Revenue for Fiscal Year 2020 Exhibit 99.1 FOR IMMEDIATE RELEASE: Item 9 Labs Reports Record Revenue for Fiscal Year 2020 · Annual revenue growth of 65% fueled by increases in production and market demand · Stage is set for 2021 developments across Arizona cannabis product expansion and new distribution through merger with national dispensary franchise PHOENIX – January 13, 2021 – Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs” |
|
| January 13, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0112form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 13, 2021 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incor |
|
| January 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED) For the fiscal year ended September 30, 2020 ☐ TRANSACTION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transaction period from to ITEM 9 LABS CORP. (Exact name of regis |
|
| December 29, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report |
|
| December 23, 2020 |
- SCHEDULE 14C PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☑ Preliminary Information Sheet ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ITEM 9 LABS CORP. (Exact name of registrant as speci |
|
| December 14, 2020 |
Agreement and Plan of Merger between Item 9 Labs Corp, I9 Acquisition Sub, Inc., and OCG Inc. Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among ITEM 9 LABS CORP. and I9 ACQUISITION SUB, INC. and OCG, INC. and PRINCIPALS and STOCKHOLDER REPRESENTATIVE December 13, 2020 TABLE OF CONTENTS Article I Definitions 2 Article II The Merger 16 Section 2.01 The Merger. 16 Section 2.02 Closing. 16 Section 2.03 Closing Deliverables. 16 Section 2.04 Effective Time 19 Section 2.05 Effects of the Merger. 19 |
|
| December 14, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: December 14, 2020 (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of inco |
|
| December 14, 2020 |
EX-99.1 3 inlb1214form8k991.htm EXHIBIT 99.1 Exhibit 99.1 |
|
| November 5, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb1105form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 5, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incor |
|
| November 5, 2020 |
Exhibit 99.1 Arizona’s Largest Approved Cultivation Site Ready for Adult-Use Market Thursday, November 5, 2020 Item 9 Labs Corp. Well Positioned for Passing of Proposition 207; Expects Accelerated Revenue Growth with Planned Arizona Expansion Already in Motion PHOENIX, AZ / ACCESSWIRE / November 5, 2020 / The future is bright for Arizona-based Item 9 Labs Corp. (OTCQX:INLB) ("Item 9 Labs," or the |
|
| October 29, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Expects to Report Record Revenue Growth of At Least 80% Year-Over-Year for Quarter Ended September 30, 2020 Expansion Plans in Place Ahead of Expected Arizona Adult Legalization and Closing of One Cannabis Group Merger Phoenix, AZ – Accesswire - October 29, 2020 – Item 9 Labs Corp. (OTCQX: INLB) (“Item 9 Labs,” or the “Company”), a vertically integrat |
|
| October 29, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: October 29, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificat |
|
| August 17, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0816form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 17, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorp |
|
| August 17, 2020 |
EX-99.1 2 inlb0816form8kexh991.htm EXHIBIT 99.1 Exhibit 99.1 Item 9 Labs Reports Fiscal Third Quarter 2020 Results Record Revenues and Quarterly Growth of 43% Alongside Reduced Operating Expenses Leads to 70% Improvement in Operating Loss to $0.2 Million and Continued Margin Expansion PHOENIX, AZ – Accesswire – August 17, 2020 – Item 9 Labs Corp. (OTCQB: INLB) (“Item 9 Labs” or the “Company”), a v |
|
| August 14, 2020 |
10-Q 1 inlb0813form10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file numb |
|
| August 6, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Names Former Best Buy President of US Retail to Board of Directors Mike Keskey, an Architect of Best Buy’s Greatest Growth Phase, Joins Board to Guide Company Through National Franchise and Supply-Chain Expansion PHOENIX (August 6, 2020) – Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated cannabis operator that pr |
|
| August 6, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 6, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificatio |
|
| August 3, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: August 3, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorporation) File Number) Identificatio |
|
| August 3, 2020 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Item 9 Labs Corp. Upgrades to OTCQB Listing Vertically Integrated Cannabis Operator Meets High Financial Standards and Other Stringent Requirements to Graduate to OTCQB, Building Visibility Among U.S. Investors PHOENIX – Item 9 Labs Corp. (OTCQB: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated cannabis operator that produces award-winning products |
|
| May 18, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 inlb0518form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: May 18, 2020 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorpora |
|
| May 18, 2020 |
Exhibit 99.1 Item 9 Labs Corp. Reports Second Quarter Fiscal Year 2020 Results Revenue Growth of 65% Expanding into Nevada and Global Franchising PHOENIX, AZ – Accesswire - May 18, 2020 - Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a vertically integrated multi-state cannabis operator producing best-in-class products, today announced the Company’s operating and financial result |
|
| May 15, 2020 |
10-Q 1 inlb0514form10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file num |
|
| April 21, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Amendment No. 1 Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☑ Preliminary Information Sheet ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ITEM 9 LABS CORP. (Exact name of reg |
|
| April 16, 2020 |
April 15, 2020 Andrew Bowden Chief Executive Officer Item 9 Labs Corp. 2727 North 3rd Street, Suite 201 Phoenix, AZ 85004 Re: Item 9 Labs Corp. Preliminary Information Statement on Schedule 14C Filed March 6, 2020 File No. 000-54730 Dear Mr. Bowden: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their |
|
| April 16, 2020 |
April 15, 2020 Andrew Bowden Chief Executive Officer Item 9 Labs Corp. 2727 North 3rd Street, Suite 201 Phoenix, AZ 85004 Re: Item 9 Labs Corp. Preliminary Information Statement on Schedule 14C Filed March 6, 2020 File No. 000-54730 Dear Mr. Bowden: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their |
|
| April 7, 2020 |
CORRESP 1 filename1.htm Item 9 Labs Corp. 2727 North 3rd Street, Suite 201 Phoenix, AZ 85004 Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 April 7, 2020 Re: Item 9 Labs Corp. Preliminary Information Statement on Schedule 14C Filed March 6, 2020 File No. 000-54730 Dear Mr. Gabor: Reference is made to the Staff’s comment letter dated Mar |
|
| March 17, 2020 |
March 17, 2020 Andrew Bowden Chief Executive Officer Item 9 Labs Corp. 2727 North 3rd Street, Suite 201 Phoenix, AZ 85004 Re: Item 9 Labs Corp. Preliminary Information Statement on Schedule 14C Filed March 6, 2020 File No. 000-54730 Dear Mr. Bowden: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better |
|
| March 17, 2020 |
March 17, 2020 Andrew Bowden Chief Executive Officer Item 9 Labs Corp. 2727 North 3rd Street, Suite 201 Phoenix, AZ 85004 Re: Item 9 Labs Corp. Preliminary Information Statement on Schedule 14C Filed March 6, 2020 File No. 000-54730 Dear Mr. Bowden: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better |
|
| March 6, 2020 |
INLB / Item 9 Labs Corp. PRE 14C - - SCHEDULE 14C PRELIMINARY INFORMATION STATEMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☑ Preliminary Information Sheet ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement ITEM 9 LABS CORP. (Exact name of registrant as speci |
|
| March 2, 2020 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: March 2, 2020 (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of incorpor |
|
| March 2, 2020 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER AMONG ITEM 9 LABS CORP., a Delaware Corporation, and OCG, Inc., a Colorado Corporation, and [MERGER SUB], a Colorado Corporation and February 27, 2020 AGREEMENT AND PLAN OF MERGER This Agreement and Plan of Merger (this “Agreement”) is dated as February 27, 2020, by and among Item 9 Labs Corp., a Delaware corporation (the “Company”), [ ], a Colorado corpora |
|
| February 19, 2020 |
INLB / Item 9 Labs Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| February 18, 2020 |
INLB / Item 9 Labs Corp. NT 10-Q - - FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER NOTIFICATION OF LATE FILING 46564C203 ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: December 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report o |
|
| February 18, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: February 18, 2020 (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IRS Employer of inco |
|
| February 7, 2020 |
8-K 1 inlb0207form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: February 7, 2020 (February 4, 2020) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of |
|
| January 14, 2020 |
INLB / Item 9 Labs Corp. 10-K - Annual Report - FORM 10-K 10-K 1 inlb0112form10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☑ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (FEE REQUIRED) For the fiscal year ended September 30, 2019 ☐ TRANSACTION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (NO FEE REQUIRED) For the transaction period from to I |
|
| January 9, 2020 |
EXHIBIT 16.1 January 9, 2020 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street NE Washington, DC 20549 Re: Item 9 Labs Corp. Ladies and Gentlemen: We have read the statements under item 4.01 in the Form 8-K dated January 9, 2020, of Item 9 Labs Corp. fka Airware Labs Corp. (the “Company”) to be filed with the Securities and Exchange Commission and we agree with su |
|
| January 9, 2020 |
8-K 1 inlb0108form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: January 9, 2020 (January 7, 2020) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of ot |
|
| December 30, 2019 |
INLB / Item 9 Labs Corp. NT 10-K - - FORM 12B-25 NT 10-K 1 inlb1230formnt10k.htm FORM 12B-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 46564C 203 NOTIFICATION OF LATE FILING ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transi |
|
| November 19, 2019 |
8-K 1 inlb1119form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: November 19, 2019 (November 15, 2019) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State o |
|
| September 4, 2019 |
Exhibit 10.1 LOAN AGREEMENT DATE: August 28, 2019 LENDER: AENEAS VENTURE PARTNERS 3, LLC an Arizona limited liability company 3120 West Carefree Highway, Suite 1-229 Phoenix, AZ 85086 Attn: Joseph Villasenor BORROWER: ITEM 9 PROPERTIES, LLC (collectively) a Nevada limited liability company 2033 N. Overfield Rd. Casa Grande, AZ 85194 Attn: Bryce Skalla BSSD GROUP, LLC an Arizona limited liability c |
|
| September 4, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report: September 4, 2019 (August 28, 2019) (Date of earliest event reported) ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 96-0665018 (State of other jurisdiction (Commission (IR |
|
| September 4, 2019 |
Item 9 Labs Corp Becomes a Fully Reporting SEC Issuer Exhibit 99.1 FOR IMMEDIATE RELEASE: Item 9 Labs Corp Becomes a Fully Reporting SEC Issuer Advancing the Company's Planned uplisting to the OTCQX PHOENIX, August 30, 2019 - Item 9 Labs Corp. (OTC: INLB) (“Item 9 Labs” or the “Company”), a leader in comfortable cannabis health solutions for the modern consumer, announced it is a Fully Reporting Company with the U.S. Securities and Exchange Commissio |
|
| September 4, 2019 |
September 4, 2019 Robert Mikkelson Chief Financial Officer Item 9 Labs Corp. 1709 East Bethany Home Road Phoenix, AZ 85016 Re: Item 9 Labs Corp. Registration Statement on Form 10-12G Filed June 27, 2019 File No. 000-54730 Dear Mr. Mikkelson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosu |
|
| September 4, 2019 |
INLB / Item 9 Labs Corp. TEXT-EXTRACT - - September 4, 2019 Robert Mikkelson Chief Financial Officer Item 9 Labs Corp. 1709 East Bethany Home Road Phoenix, AZ 85016 Re: Item 9 Labs Corp. Registration Statement on Form 10-12G Filed June 27, 2019 File No. 000-54730 Dear Mr. Mikkelson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosu |
|
| August 23, 2019 |
INLB / Item 9 Labs Corp. CORRESP - - CORRESP 1 filename1.htm Item 9 Labs Corp. 1709 East Bethany Home Road Phoenix, AZ 85016 Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 August 22, 2019 Re: Item 9 Labs Corp. Registration Statement on Form 10-12G Filed June 27, 2019 File No. 000-54730 Dear Mr. Stickel: Reference is made to the Staff’s comment letter dated July 22, 2019 (t |
|
| August 22, 2019 |
Filed with the SEC on August 22, 2019 as an exhibit to our Registration Statement on Form 10-12G/A Exhibit 10.10 CONFIDENTIAL TERM SHEET June 15, 2018 STRIVE WELLNESS OF NEVADA, LLC a Nevada limited liability company We are offering and selling a specified portion (defined herein) of the total membership interests (collectively referred to herein as “Interests” and each individually, as a “Interest”) in Company (defined herein) only to Item9 (defined herein) as an accredited investor, in relian |
|
| August 22, 2019 |
INLB / Item 9 Labs Corp. 10-12G/A - - FORM 10 (AMENDMENT NO. 1) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10 AMENDMENT NO. 1 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 98-0665018 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification |
|
| August 22, 2019 |
Exhibit 21 Subsidiaries of Registrant Name State of Incorporation or Organization BSSD Group, LLC Arizona AZ DP Holdings, LLC Nevada BSSD Consulting, LLC Arizona Strive Life Management, LLC Arizona I9 IP Holdings, LLC Arizona I9 Management, LLC Arizona Item 9 Properties LLC Nevada Strive Management LLC * Nevada Airware Holdings LLC Nevada *Minority Interest |
|
| August 16, 2019 |
Purchase Agreement between Sidewinder Dairy, Inc. and the Company dated April 20, 2018 Exhibit 10.05 PURCHASE AGREEMENT among Sidewinder Dairy, Inc., an Arizona corporation (“Seller”) and AIRWARE LABS CORP. A DELAWARE CORPORATION (“Buyer”) dated as of April 20th, 2018 PURCHASE AGREEMENT This Purchase Agreement (this “Agreement”), dated as of April 20th, 2018 (the “Effective Date”), is entered into amongst, Sidewinder Dairy, Inc., an Arizona corporation, 2734 E. Kortsen Road and 2033 |
|
| August 16, 2019 |
INLB / Item 9 Labs Corp. 10-Q - Quarterly Report - FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☑ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-54730 ITEM 9 LABS CORP. |
|
| August 14, 2019 |
AIRW / Airware Labs Corp. NT 10-Q - - FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washing, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12B-25 CUSIP NUMBER 46564C203 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ |
|
| July 22, 2019 |
INLB / Item 9 Labs Corp. TEXT-EXTRACT - - July 22, 2019 Robert Mikkelson Chief Financial Officer Item 9 Labs Corp. 1709 East Bethany Home Road Phoenix, AZ 85016 Re: Item 9 Labs Corp. Registration Statement on Form 10-12G Filed June 27, 2019 File No. 000-54730 Dear Mr. Mikkelson: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand y |
|
| July 22, 2019 |
July 22, 2019 Robert Mikkelson Chief Financial Officer Item 9 Labs Corp. 1709 East Bethany Home Road Phoenix, AZ 85016 Re: Item 9 Labs Corp. Registration Statement on Form 10-12G Filed June 27, 2019 File No. 000-54730 Dear Mr. Mikkelson: We have reviewed your filing and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understand y |
|
| June 26, 2019 |
Certificate of Amendment to Articles of Incorporation dated October 9, 2018 EX-3.01F 5 airw0614form10exh301f.htm EXHIBIT 3.01F Exhibit 3.01f |
|
| June 26, 2019 |
Exhibit 10.6 LOAN AND Revenue PARTICIPATION AGREEMENT This Loan and Revenue Participation Purchase Agreement (the "Agreement") is made as of September, 2018 (the "Effective Date") by and among Item 9 Labs Corp., a Delaware corporation (the "Item 9 Labs"), BSSD Group, LLC, an Arizona limited liability company (“Arizona Subsidiary”), Item 9 Properties, LLC, a Nevada limited liability company (“Nevad |
|
| June 26, 2019 |
AIRW / Airware Labs Corp. 10-12G - - FORM 10 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10 GENERAL FORM FOR REGISTRATION OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 ITEM 9 LABS CORP. (Exact name of registrant as specified in its charter) Delaware 98-0665018 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 1709 East B |
|
| June 26, 2019 |
EX-10.4 7 airw0614form10exh104.htm EXHIBIT 10.4 Exhibit 10.4 AGREEMENT AND PLAN OF EXCHANGE THIS AGREEMENT AND PLAN OF EXCHANGE (this "Agreement") is made and entered into as of the 26th day of January 2018 (the “Effective Date”) by and among Airware Labs Corp, a Delaware limited liability company (“ALC”), and Airware Holdings, Inc., a Nevada corporation Arizona (“AHI”), on the one hand, and BSSD |
|
| June 26, 2019 |
Certificate of Amendment to Articles of Incorporation dated March 15, 2018 Exhibit 3.01c |
|
| June 26, 2019 |
Certificate of Amendment to Articles of Incorporation dated March 19, 2018 Exhibit 3.01d |
|
| June 26, 2019 |
Asset Purchase Agreement between Item 9 Labs Corp. and AZ DP Consulting, LLC dated November 26, 2018 EX-10.5 8 airw0614form10exh105.htm EXHIBIT 10.5 Exhibit 10.5 ASSET PURCHASE AGREEMENT by and between ARIZONA DP CONSULTING LLC, the Individual Member of ARIZONA DP CONSULTING LLC, AZ DP HOLDINGS, LLC and ITEM 9 LABS CORP. Dated: NOVEMBER 26, 2018 TABLE OF CONTENTS Page Article I. DEFINITIONS 1 Article II. PURCHASE AND SALE 5 Article III. CLOSING 8 Article IV. REPRESENTATIONS AND WARRANTIES OF SELL |
|
| June 26, 2019 |
Certificate of Amendment to Articles of Incorporation dated April 3, 2018 Exhibit 3.01e |
|
| June 26, 2019 |
Nominations and Governance Committee Charter EX-99.3 15 airw0614form10exh993.htm EXHIBIT 99.3 Exhibit 99.3 EXHIBIT D ITEM 9 LABS CORP. Nominations and Governance Committee Charter I. Mission Statement The Nominations and Governance Committee (the “Committee”) is established by the Board of Directors (the “Board”) of ITEM 9 LABS CORP. (the “Company”). The purpose of the Committee is to assist the Board in fulfilling its fiduciary responsibili |
|
| June 26, 2019 |
EX-4.1 6 airw0614form10exh41.htm EXHIBIT 4.1 Exhibit 4.1 ITEM 9 LABS CORP. 2019 EQUITY INCENTIVE PLAN 1. Purpose of the Plan. The purpose of this Plan is to encourage ownership in Item 9 Labs Corp. (the “Company”) by key personnel whose long-term service the Company considers essential to its continued progress and, thereby, encourage recipients to act in the stockholders’ interest and share in th |
|
| June 26, 2019 |
Exhibit 14.1 EXHIBIT A ITEM 9 LABS CORP. (THE “COMPANY”) CODE OF CONDUCT AND ETHICS INTRODUCTION This Code of Conduct and Ethics (the “Code”) of the Company applies to the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, pursuant to Item 406 of Regulation S-K, as well as directors, officers, and |
|
| June 26, 2019 |
Exhibit 21 Subsidiaries of Registrant Name State of Incorporation or Organization BSSD Group, LLC Arizona AZ DP Holdings, LLC Nevada BSSD Consulting, LLC Arizona Strive Life Management, LLC Arizona I9 IP Holdings, LLC Arizona I9 Management, LLC Arizona Item 9 Properties LLC Nevada Strive Management LLC Nevada Airware Holdings LLC Nevada |
|
| June 26, 2019 |
EX-99.1 13 airw0614form10exh991.htm EXHIBIT 99.1 Exhibit 99.1 EXHIBIT B ITEM 9 LABS CORP. Audit Committee Charter I. Mission Statement The Audit Committee (the “Committee”) is established by the Board of Directors (the “Board”) of ITEM 9 LABS CORP. (the “Company”). The purpose of the Committee is to assist the Board in fulfilling its oversight responsibilities related to: (i) appointing, overseein |
|
| June 26, 2019 |
Compensation Committee Charter EX-99.2 14 airw0614form10exh992.htm EXHIBIT 99.2 Exhibit 99.2 EXHIBIT C ITEM 9 LABS CORP. Compensation Committee Charter I. Mission Statement The Compensation Committee (the “Committee”) is established by the Board of Directors (the “Board”) of ITEM 9 LABS CORP. (the “Company”). The purpose of the Committee is to assist the Board in fulfilling its oversight responsibilities related to the Company’ |
|
| June 26, 2019 |
Employment Agreement with Sara Gullickson dated November 26, 2018 EX-10.8 10 airw0614form10exh108.htm EXHIBIT 10.8 Exhibit 10.8 EXECUTIVE EMPLOYMENT AGREEMENT This Employment Agreement ("Agreement") is effective on November 26, 2018 (the “Effective Date”) between Item 9 Labs Corp., a Delaware corporation ("Company") and Sara Gullickson ("Executive"). The Company and Executive are sometimes referred to herein individually as a “Party” and collectively as the “Par |
|
| December 21, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 000-54730 AIRWARE LABS CORP. (Exact name of registrant as specified in its |
|
| September 29, 2016 |
Changes in Control of Registrant, Unregistered Sales of Equity Securities 8-K 1 airw0929form8k.htm FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 29, 2016 (September 19, 2016) AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jur |
|
| August 19, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 19, 2016 |
Airware Labs FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant as sp |
|
| August 19, 2016 |
Airware Labs FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant as sp |
|
| August 19, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 19, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| August 19, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 19, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| August 19, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| August 19, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 19, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| August 15, 2016 |
NT 10-Q 1 airw0812formnt10q.htm FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 00951F105 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report |
|
| August 15, 2016 |
NT 10-Q 1 airw0812formnt10q.htm FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 00951F105 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: June 30, 2016 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report |
|
| May 16, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| May 16, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| May 16, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| May 16, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2016; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| May 16, 2016 |
Airware Labs FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant as s |
|
| April 7, 2016 |
Mail Stop 3030 April 7, 2016 Via E-mail Jessica Smith Chief Financial Officer Airware Labs Corp. |
|
| April 5, 2016 |
Airware Labs FORM 10-K/A AMENDMENT NO. 1 (Annual Report) 10-K/A 1 airw0405form10ka.htm FORM 10-K/A AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the yearly period ended September 30, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transitio |
|
| April 5, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Annual Report on Form 10-K/A of the Registrant for the year ended September 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| April 5, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge, th |
|
| April 5, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Repor |
|
| April 5, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Annual Report on Form 10-K/A of the Registrant for the year ended September 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| April 5, 2016 |
Airware Labs Corp. 7377 E. Doubletree Ranch Rd., Suite 260 Scottsdale, AZ 85258 April 5, 2016 Mr. Martin James, Senior Assistant Chief Accountant Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Airware Labs Corp. Form 10-K for the fiscal year ended September 30, 2015 Filed March 4, 2016 File No. 000-54730 Dear Mr. James: Airware Labs |
|
| March 30, 2016 |
Mail Stop 3030 March 29, 2016 Via E-mail Jessica Smith Chief Financial Officer Airware Labs Corp. |
|
| March 28, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| March 28, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| March 28, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| March 28, 2016 |
Airware Labs FORM 10-Q (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2015 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant a |
|
| March 28, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| March 4, 2016 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge, th |
|
| March 4, 2016 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Repor |
|
| March 4, 2016 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Annual Report on Form 10-K of the Registrant for the year ended September 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| March 4, 2016 |
Airware Labs FORM 10-K (Annual Report) 10-K 1 airw0302form10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the yearly period ended September 30, 2015 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . AIRWARE LABS CORP. ( |
|
| March 4, 2016 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Annual Report on Form 10-K of the Registrant for the year ended September 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| December 29, 2015 |
NT 10-K 1 airw1229formnt10k.htm FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 00951F105 NOTIFICATION OF LATE FILING ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2015 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Re |
|
| October 13, 2015 |
TENTH ALLONGE TO SENIOR SECURED CONVERTIBLE NOTE Exhibit 10.1 TENTH ALLONGE TO SENIOR SECURED CONVERTIBLE NOTE This TENTH Allonge (the "Tenth Allonge"), dated as of August 31, 2015, attached to and forming a part of the Senior Secured Convertible Note, dated December 14, 2009 (collectively, the "Note"), made by AIRWARE HOLDINGS, INC., a Nevada corporation (the "Company") F/K/A AirWare, Inc., payable to the order of STOCKBRIDGE ENTERPRISES, L.P., |
|
| October 13, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 13, 2015 (August 31, 2015) AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jurisdiction (Commission File Number) (IRS |
|
| August 19, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 19, 2015 (August 17, 2015) AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jurisdiction (Commission File Number) (IRS |
|
| August 12, 2015 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 12, 2015 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| August 12, 2015 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| August 12, 2015 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 12, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant as sp |
|
| May 19, 2015 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| May 19, 2015 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| May 19, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant as s |
|
| May 19, 2015 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| May 19, 2015 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2015; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| May 15, 2015 |
NT 10-Q 1 airw0516formnt10q.htm FORM NT 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 00951F105 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: March 31, 2015 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Repor |
|
| February 20, 2015 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| February 20, 2015 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2014 ? TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant a |
|
| February 20, 2015 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 20, 2015 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| February 17, 2015 |
INLB / Item 9 Labs Corp. NT 10-Q - - FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SEC FILE NUMBER 000-54730 FORM 12b-25 CUSIP NUMBER 00951F105 NOTIFICATION OF LATE FILING ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☑ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: December 31, 2014 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form |
|
| January 22, 2015 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 22, 2015 (January 16, 2015) AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jurisdiction (Commission File Number) (IR |
|
| January 22, 2015 |
EX-16.1 2 airw0121form8kexh161.htm EXHIBIT 16.1 Exhibit 16.1 January 22, 2015 U.S. Securities and Exchange Commission Office of the Chief Accountant 100 F Street NE Washington, DC 20549 Re: Airware Labs Corp. Ladies and Gentlemen: We have read the statements under item 4.01 in the Form 8-K dated January 22, 2015, of Airware Labs Corp. (the “Company”) to be filed with the Securities and Exchange Co |
|
| January 9, 2015 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Annual Report on Form 10-K of the Registrant for the year ended September 30, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| January 9, 2015 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Annual Report on Form 10-K of the Registrant for the year ended September 30, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| January 9, 2015 |
10-K 1 airw0107form10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the yearly period ended September 30, 2014 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . AIRWARE LABS CORP. ( |
|
| January 9, 2015 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Repor |
|
| January 9, 2015 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certifies, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to her knowledge, th |
|
| December 29, 2014 |
INLB / Item 9 Labs Corp. NT 10-K - - FORM 12B-25 U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-54730 CUSIP NUMBER 00951F105 ☑ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For period ended: September 30, 2014 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on For |
|
| October 21, 2014 |
October 21, 2014 Via Email Jessica Smith Chief Accounting and Financial Officer Airware Labs Corp. |
|
| October 14, 2014 |
INLB / Item 9 Labs Corp. CORRESP - - Airware Labs Corp. 7377 E. Double Tree Ranch Rd., Suite 260 Scottsdale, AZ 85258 October 14, 2014 Mr. Brian Cascio, Accounting Branch Chief Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Re: Airware Labs Corp. Form 10-K for the fiscal year ended September 30, 2013 Filed January 13, 2014 Form 10-Q for the quarterly period ended June 30, 2 |
|
| September 25, 2014 |
September 25, 2014 Via Email Jessica Smith Chief Accounting and Financial Officer Airware Labs Corp. |
|
| August 14, 2014 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| August 14, 2014 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 14, 2014 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| August 14, 2014 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary t |
|
| August 14, 2014 |
10-Q 1 airw0812form10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS |
|
| May 23, 2014 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 23, 2014 (May 21, 2014) AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jurisdiction (Commission File Number) (IRS Employ |
|
| May 15, 2014 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
|
| May 15, 2014 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| May 15, 2014 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| May 15, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 [] TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant a |
|
| May 15, 2014 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended March 31, 2014; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary |
|
| February 28, 2014 |
Unregistered Sales of Equity Securities - FORM 8-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 28, 2014 AIRWARE LABS CORP. (Exact name of registrant as specified in its charter) Delaware 000-54730 98-0665018 (State or other jurisdiction (Commission File Number) (IRS Employer of Inco |
|
| February 14, 2014 |
EXHIBIT 31.01 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2013; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 14, 2014 |
EXHIBIT 32.02 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, the Chief Accounting and Financial Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Q |
|
| February 14, 2014 |
EXHIBIT 31.02 CERTIFICATION OF PRINCIPAL ACCOUNTING OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002 I, Jessica Smith, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of the Registrant for the period ended December 31, 2013; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessa |
|
| February 14, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2013 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT OF 1934 For the transition period from: Commission File Number 000-54730 AIRWARE LABS CORP. (Exact name of registrant a |
|
| February 14, 2014 |
EXHIBIT 32.01 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 I, Jeffrey Rassas, the Chief Executive Officer of Airware Labs Corp., certify, under the standards set forth and solely for the purposes of 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge, the Quarterly Repor |
